Last reviewed · How we verify

MIS — Competitive Intelligence Brief

MIS (MIS) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Plasma-derived immunoglobulin preparation or blood product. Area: Hematology / Immunology.

marketed Plasma-derived immunoglobulin preparation or blood product Hematology / Immunology Biologic Live · refreshed every 30 min

Target snapshot

MIS (MIS) — Blood Transfusion Centre of Slovenia. MIS is a blood product derived from donated human blood that restores or replaces deficient blood components.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
MIS TARGET MIS Blood Transfusion Centre of Slovenia marketed Plasma-derived immunoglobulin preparation or blood product

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Plasma-derived immunoglobulin preparation or blood product class)

  1. Blood Transfusion Centre of Slovenia · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). MIS — Competitive Intelligence Brief. https://druglandscape.com/ci/mis. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: